VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS20000402 | HPV | ENSG00000164867.11 | protein_coding | NOS3 | No | No | 4846 | P29474 |
TVIS20061493 | HPV | ENSG00000164867.11 | protein_coding | NOS3 | No | No | 4846 | P29474 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | NOS3 |
---|---|
DrugBank ID | DB00435 |
Drug Name | Nitric Oxide |
Target ID | BE0000263 |
UniProt ID | P29474 |
Regulation Type | product of |
PubMed IDs | 12411399 |
Citations | Rossig L, Li H, Fisslthaler B, Urbich C, Fleming I, Forstermann U, Zeiher AM, Dimmeler S: Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. Circ Res. 2002 Nov 1;91(9):837-44. doi: 10.1161/01.res.0000037983.07158.b1. |
Groups | Approved |
Direct Classification | Other non-metal oxides |
SMILES | [N]=O |
Pathways | Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]; Ornithine Aminotransferase Deficiency (OAT Deficiency); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Hyperprolinemia Type I; Hyperprolinemia Type II; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Prolidase Deficiency (PD); Nitric Oxide Signaling Pathway; Arginine and Proline Metabolism; Hyperornithinemia with Gyrate Atrophy (HOGA); Prolinemia Type II; L-Arginine:Glycine Amidinotransferase Deficiency; Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency |
PharmGKB | PA450635 |
ChEMBL | CHEMBL1200689 |